Tricida operates in the healthcare industry focusing on pharmaceutical business.
Tricida has raised $125.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in October 2022.
Tricida's investors include Cormorant Asset Management, Vivo Capital, Wellington Management, Venrock, OrbiMed.
Tricida is headquartered in Menlo Park, United States.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Tricida is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tricida — Funding & Investors." VCBacked, October 19, 2022, https://www.vcbacked.co/company/tricida. Accessed July 19, 2026.
VCBacked. (2022). Tricida — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tricida
{{cite web |title=Tricida — Funding & Investors |url=https://www.vcbacked.co/company/tricida |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated